Main menu

Methylation with Oxford Nanopore Technologies

Get startedSubscribe
Return to Resources

During this seminar, we heard from Danielle Folkard, Strategic Account Manager - UK & Ireland, Oxford Nanopore Technologies Ltd., who gave an overview of the platform before we were joined by Chloe Goldsmith, Lyon Cancer Research Center, and Adrien Leger, EMBL-European Bioinformatics Institute, who each presented their latest research with nanopore sequencing.

Authors: Danielle Folkard,, Chloe Goldsmith, and Adrien Leger
Find out more about epigenetics with nanopore sequencing
  • Published on: December 31 2020

入門

MinION Starter Packを購入 ナノポア製品の販売 シークエンスサービスプロバイダー グローバルディストリビューター

お問い合わせ

Intellectual property Cookie policy Corporate reporting Privacy policy Terms & conditions Accessibility

Oxford Nanoporeについて

Contact us 経営陣 メディアリソース & お問い合わせ先 投資家向け Oxford Nanopore社で働く BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust

© 2008 - 2023 Oxford Nanopore Technologies plc. All rights reserved. 登記された事務所：Gosling Building,\n Edmund Halley Road, Oxford Science Park, OX4 4DQ, UK {'|'} 登記番号：05386273 {'|'} VAT番号：336942382。Oxford\n Nanopore Technologies、Wheel icon、EPI2ME、Flongle、GridION、Metrichor、MinION、MinIT、MinKNOW、Plongle、\n PromethION、SmidgION、UbikおよびVolTRAXは様々な国で登録されたOxford Nanopore Technologies\nの商標です。Oxford Nanopore Technologies製品は、\n現在すべて研究用です。

Japanese flag